Skip to content
MedicationQ30315101· pop 9· linked from 355 articles

cenegermin

Sign in to save

Cenegermin, sold under the brand name Oxervate, also known as recombinant human nerve growth factor, is a recombinant form of human nerve growth factor. Cenegermin is a peripherally selective agonist of the tropomyosin receptor kinase A (TrkA) and low-affinity nerve growth factor receptor (p75NTR).

In the Vinony graph

Vinony's link graph records 355 inbound references to cenegermin, and connects out to World Health Organization, digital object identifier and chemical formula.

Vinony files it under Chemicals that do not have a ChemSpider ID assigned, Drugs with non-standard legal status and Infobox drug articles without a structure image.

Vinony links it to 9 Wikipedia language editions.

Clinical Trials

10 registered

via ClinicalTrials.gov

~1 min read

Encyclopedic overview

5 sections
Contents
  • Medical uses
  • Society and culture
  • Names
  • References
  • Further reading

Cenegermin, sold under the brand name Oxervate, also known as recombinant human nerve growth factor, is a recombinant form of human nerve growth factor. Cenegermin is a peripherally selective agonist of the tropomyosin receptor kinase A (TrkA) and low-affinity nerve growth factor receptor (p75NTR).

The most common side effects include eye pain and inflammation, increased lacrimation (watery eyes), pain in the eyelid and sensation of a foreign body in the eye.

Excerpted from Wikipedia’s “cenegermin” article, available under the CC BY-SA 4.0 licence.

Available in 9 languages

via Wikidata sitelinks · CC0

Connections

Categories